Microscopic polyangiitis: Clinical presentation

Autoimmunity Reviews

Volumn 9, Issue 12, 2010, Pages 812-819

  Villiger, Peter M ^a   Guillevin, Loïc ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSERM   (France)

Author keywords

ANCA; Cyclophosphamide; Intravenous immunoglobulins; Microscopic polyangiitis; Plasma exchanges; Pulmo renal syndromes; Rituximab; Vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; RITUXIMAB; STEROID;

CENTRAL NERVOUS SYSTEM DISEASE; CHILL; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG ERUPTION; DRUG INDICATION; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; EYE DISEASE; FEVER; GASTROINTESTINAL DISEASE; HEADACHE; HEART DISEASE; HISTOPATHOLOGY; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LOW BACK PAIN; LUNG DISEASE; LUNG FIBROSIS; MAINTENANCE THERAPY; MICROSCOPIC POLYANGIITIS; MONOTHERAPY; MUSCULOSKELETAL DISEASE; NAUSEA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PREVALENCE; PROGNOSIS; REMISSION; REVIEW; SEX DIFFERENCE; SIDE EFFECT; SKIN DISEASE; SWEATING; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; KIDNEY; LUNG; MICROSCOPIC POLYANGIITIS; PLASMAPHERESIS; SKIN;

EID: 77956912123     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.07.009     Document Type: Review

References (80)

1. Wohlwill F. Uber die nur Mikroskopisch erkenbarre Form der Periarteritis nodosa. Arch Pathol Anat 1923, 246:377-411.
2. Davson J., Ball J., Platt R. The kidney in periarteritis nodosa. Q J Med Jul 1948, 17(67):175-202.
3. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum Feb 1994, 37(2):187-192.
4. Guillevin L., Durand-Gasselin B., Cevallos R., Gayraud M., Lhote F., Callard P., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum Mar 1999, 42(3):421-430.
5. Savage C., Winearls C., Evans D., Rees A., Lockwood C. Microscopic polyarteritis: presentation, pathology and prognosis. QJM 1985, 56:467-483.
6. Serra A., Cameron J., Turner D., Hartley B., Ogg C., Neild G., et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. QJM 1984, 53:181-207.
7. D'Agati V., Chander P., Nash M., Mancilla-Jimenez R. Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis Jan 1986, 7(1):95-110.
8. Adu D., Howie A.J., Scott D.G., Bacon P.A., McGonigle R.J., Micheal J. Polyarteritis and the kidney. Q J Med Mar 1987, 62(239):221-237.
9. Mahr A. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?. APMIS 2009, Suppl.127:41-47.
10. Pagnoux C., Mahr A., Hamidou M.A., Boffa J.J., Ruivard M., Ducroix J.P., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med Dec 25 2008, 359(26):2790-2803.
11. Watts R.A., Scott D.G., Jayne D.R., Ito-Ihara T., Muso E., Fujimoto S., et al. Renal vasculitis in Japan and the UK-are there differences in epidemiology and clinical phenotype?. Nephrol Dial Transplant Dec 2008, 23(12):3928-3931.
12. Suzuki Y., Takeda Y., Sato D., Kanaguchi Y., Tanaka Y., Kobayashi S., et al. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan. Mod Rheumatol Feb 2010, 20(1):54-62.
13. Watts R.A., Scott D.G. Epidemiology of the vasculitides. Semin Respir Crit Care Med Oct 2004, 25(5):455-464.
14. Watts R.A., Gonzalez-Gay M.A., Lane S.E., Garcia-Porrua C., Bentham G., Scott D.G. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis Feb 2001, 60(2):170-172.
15. Mahr A., Guillevin L., Poissonnet M., Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum Feb 15 2004, 51(1):92-99.
16. Mohammad A.J., Jacobsson L.T., Mahr A.D., Sturfelt G., Segelmark M. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatol (Oxf) Aug 2007, 46(8):1329-1337.
17. Gatenby P., Lucas R., Engelsen O., Ponsonby A., Clements M. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?. Arthritis Rheum 2009, 61:1417-1424.
18. Reinhold-Keller E., Herlyn K., Wagner-Bastmeyer R., Gutfleisch J., Peter H.H., Raspe H.H., et al. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register. Rheumatol (Oxf) May 2002, 41(5):540-549.
19. Lee R.W., D'Cruz D.P. Pulmonary renal vasculitis syndromes. Autoimmun Rev 2010 Aug, 9(10):657-660. Epub 2010 May 21.
20. Pagnoux C., Seror R., Henegar C., Mahr A., Cohen P., Le Guern V., et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010, 62:616-626.
21. Azar N., Guillevin L., Huong Du L.T., Herreman G., Meyrier A., Godeau P. Symptomatic urogenital manifestations of polyarteritis nodosa and Churg-Strauss angiitis: analysis of 8 of 165 patients. J Urol Jul 1989, 142(1):136-138.
22. Henegar C., Pagnoux C., Puechal X., Zucker J.D., Bar-Hen A., Le Guern V., et al. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum May 2008, 58(5):1528-1538.
23. Lauque D., Cadranel J., Lazor R., Pourrat J., Ronco P., Guillevin L., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Med (Baltim) Jul 2000, 79(4):222-233.
24. Hervier B., Pagnoux C., Agard C., Haroche J., Amoura Z., Guillevin L., et al. Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis Mar 2009, 68(3):404-407.
25. Tzelepis G.E., Kokosi M., Tzioufas A., Toya S.P., Boki K.A., Zormpala A., et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010 Jul, 36(1):116-121. Epub 2009 Nov 19.
26. Zhang W., Zhou G., Shi Q., Zhang X., Zeng X., Zhang F. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 2009, 27:S65-S69.
27. Kluger N., Pagnoux C., Guillevin L., Frances C. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis. Br J Dermatol Sep 2008, 159(3):615-620.
28. Niiyama S., Amoh Y., Tomita M., Katsuoka K. Dermatological manifestations associated with microscopic polyangiitis. Rheumatol Int Apr 2008, 28(6):593-595.
29. Wang L., Thelmo W.L., Axiotis C.A. Microscopic polyangiitis with massive myocardial necrosis ans diffuse pulmonary hemorrhage. Virchows Arch Aug 2002, 441(2):202-204.
30. Messmer E.M., Foster C.S. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999 Mar-Apr, 43(5):379-396.
31. Hara A., Ohta S., Takata M., Saito K., Torisaki M., Ishida Y., et al. Microscopic polyangiitis with ocular manifestations as the initial presenting sign. Am J Med Sci Oct 2007, 334(4):308-310.
32. Mihara M., Hayasaka S., Watanabe K., Kitagawa K., Hayasaka Y. Ocular manifestations in patients with microscopic polyangiitis. Eur J Ophthalmol Jan-Feb 2005, 15(1):138-142.
33. Altaie R., Ditizio F., Fahy G.T. Microscopic polyangitis presenting with sub-acute reversible optic neuropathy. Eye Mar 2005, 19(3):363-365.
34. Gayraud M., Guillevin L., le Toumelin P., Cohen P., Lhote F., Casassus P., et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum Mar 2001, 44(3):666-675.
35. Lhote F., Cohen P., Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998, 7(4):238-258.
36. Pagnoux C., Mahr A., Cohen P., Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Med. (Baltim) Mar 2005, 84(2):115-128.
37. Lamarche J.A., Peguero A.M., Rosario J.O., Patel A., Courville C. Anti-MPO small-vessel vasculitis causing prostatis and nephritis. Clin Exp Nephrol Jun 2007, 11(2):180-183.
38. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P., et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the FVSG cohort. Medicine (in press).
39. Ryomoto M., Mitsuno M., Nishi H., Fukui S., Miyamoto Y., Hao H. Aortic aneurysm due to microscopic polyangiitis. Ann Thorac Surg 2009, 88:2031-2034.
40. Chirinos J.A., Tamariz L.J., Lopes G., Del Carpio F., Zhang X., Milikowski C., et al. Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol Apr 2004, 23(2):152-159.
41. Pankhurst T., Savage C.O., Gordon C., Harper L. Malignancy is increased in ANCA-associated vasculitis. Rheumatol. (Oxf) Dec 2004, 43(12):1532-1535.
42. Fain O., Hamidou M., Cacoub P., Godeau B., Wechsler B., Paries J., et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum Dec 15 2007, 57(8):1473-1480.
43. Parambil J.G., Keogh K.A., Fervenza F.C., Ryu J.H. Microscopic polyangiitis associated with thymoma, exacerbating after thymectomy. Am J Kidney Dis Nov 2006, 48(5):827-831.
44. Pamuk G.E., Pamuk O.N., Umit E.G., Puyan F.O., Ozturk E., Demir M. Antineutrophil cytoplasmic antibody associated vasculitis in one patient with severe aplastic anemia: description of the first case. Leuk Res Aug 2009, 33(8):e95-e97.
45. Pamuk G.E., Uyanik M.S., Demir M., Tekgunduz E., Turgut B., Soy M. Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia: quite a rare diagnosis. Leuk Res Aug 2007, 31(8):1149-1151.
46. Garcia Pares D., Valles M., Bronsoms J., Torguet P., Mate G., Mauri J.M., et al. Microscopic polyangiitis associated with non-Hodgkin's lymphoma. Nephrol Dial Transplant Apr 1999, 14(4):1038-1040.
47. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med Mar 15 1992, 116(6):488-498.
48. Reinhold-Keller E., Beuge N., Latza U., de Groot K., Rudert H., Nolle B., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum May 2000, 43(5):1021-1032.
49. Adu D., Pall A., Luqmani R.A., Richards N.T., Howie A.J., Emery P., et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM Jun 1997, 90(6):401-409.
50. Haubitz M., Frei U., Rother U., Brunkhorst R., Koch K.M. Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transplant 1991, 6(8):531-535.
51. Guillevin L., Cohen P., Mahr A., Arene J.P., Mouthon L., Puechal X., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum Feb 15 2003, 49(1):93-100.
52. Guillevin L., Cordier J.F., Lhote F., Cohen P., Jarrousse B., Royer I., et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum Dec 1997, 40(12):2187-2198.
53. de Groot K., Harper L., Jayne D.R., Flores Suarez L.F., Gregorini G., Gross W.L., et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med May 19 2009, 150(10):670-680.
54. Jayne D., Rasmussen N., Andrassy K., Bacon P., Tervaert J.W., Dadoniene J., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med Jul 3 2003, 349(1):36-44.
55. De Groot K., Rasmussen N., Bacon P.A., Tervaert J.W., Feighery C., Gregorini G., et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum Aug 2005, 52(8):2461-2469.
56. Langford C.A., Talar-Williams C., Sneller M.C. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum Apr 15 2004, 51(2):278-283.
57. Hiemstra I., Walsh M., de Groot K., Hauser T., Mahr A., Pagnoux C., et al. Randomized trial of mycophenolate mofetil vs azathioprine for maintenance therapy in ANCA-associated vasculitis (IMPROVE). APMIS 2009, 117(supplement 127):77. A 23.
58. Pusey C.D., Rees A.J., Evans D.J., Peters D.K., Lockwood C.M. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int Oct 1991, 40(4):757-763.
59. Jayne D.R., Gaskin G., Rasmussen N., Abramowicz D., Ferrario F., Guillevin L., et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol Jul 2007, 18(7):2180-2188.
60. Tzioufas A.G., Routsias J.G. Idiotype, anti-idiotype network of autoantibodies. Pathogenetic considerations and clinical application. Autoimmun Rev Jul 2010, 9(9):631-633.
61. Jayne D.R., Chapel H., Adu D., Misbah S., O'Donoghue D., Scott D., et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM Jul 2000, 93(7):433-439.
62. Jayne D.R., Davies M.J., Fox C.J., Black C.M., Lockwood C.M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet May 11 1991, 337(8750):1137-1139.
63. Jayne D.R., Esnault V.L., Lockwood C.M. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J Autoimmun Apr 1993, 6(2):207-219.
64. Jayne D.R., Esnault V.L., Lockwood C.M. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis. J Autoimmun Apr 1993, 6(2):221-226.
65. Richter C., Schnabel A., Csernok E., De Groot K., Reinhold-Keller E., Gross W.L. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol Jul 1995, 101(1):2-7.
66. Richter C., Schnabel A., Csernok E., Reinhold-Keller E., Gross W.L. Treatment of Wegener's granulomatosis with intravenous immunoglobulin. Adv Exp Med Biol 1993, 336:487-489.
67. Martinez V., Cohen P., Pagnoux C., Vinzio S., Mahr A., Mouthon L., et al. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum Jan 2008, 58(1):308-317.
68. Bartolucci P., Ramanoelina J., Cohen P., Mahr A., Godmer P., Le Hello C., et al. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatol (Oxf) Oct 2002, 41(10):1126-1132.
69. Booth A., Harper L., Hammad T., Bacon P., Griffith M., Levy J., et al. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol Mar 2004, 15(3):717-721.
70. Josselin L., Mahr A., Cohen P., Pagnoux C., Guaydier-Souquieres G., Hayem G., et al. Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients. Ann Rheum Dis Sep 2008, 67(9):1343-1346.
71. Guillevin L., de Menthon M., Cohen P., Pagnoux C., Mahr A. French Vasculitis Study Group (FVSG). Comparison of infliximab and rituximab in Wegener's granulomatosis (WG) refractory to steroids and immunosuppressants: a prospective, randomized study on 21 patients. Arthritis Rheum 2008, supplement, 2008.
72. Ramos-Casals M., Perez-Alvarez R., Diaz-Lagares C., Cuadrado M., Khamashta M. BiOGEAS Study Group. Autoimuune diseases induced by biological agents: a double-edged sword?. Autoimmun Rev 2010, 3:188-193.
73. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med Jan 27 2005, 352(4):351-361.
74. Keogh K.A., Wylam M.E., Stone J.H., Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum Jan 2005, 52(1):262-268.
75. Specks U. Rituximab for ANCA-associated vasculitis (the RAVE-trial). Proceedings of the 14th international vasculitis and ANCA workshop. APMIS 2009, 117(supplement 127).
76. Jones R.B., Cohen Tervaert J.W., Hauser T., Luqmani R., Morgan M.D., Peh C.A., et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010 Jul 15, 363(3):211-220.
77. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Med (Baltim) Jan 1996, 75(1):17-28.
78. Ribi C., Cohen P., Pagnoux C., Mahr A., Arene J.P., Lauque D., et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum Feb 2008, 58(2):586-594.
79. Ribi C., Cohen P., Pagnoux C., Mahr A., Arène J., Puéchal X., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study on 124 patients. Arthritis Rheum 2010 Apr, 62(4):1186-1197.
80. Powell C., Chang C., Naguwa S.M., Cheema G., Gershwin M.E. Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev Jul 8 2010, Epub.